Antipyretic effect

An antipyretic effect refers to the physiological reduction of an elevated body temperature, or fever, typically induced by pharmacological intervention. It is not a molecular target itself but rather a therapeutic outcome resulting from the modulation of biochemical pathways, primarily the arachidonic acid cascade (StatPearls, 2023). Most antipyretic drugs, such as nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen, achieve this effect by inhibiting cyclooxygenase (COX) enzymes, which in turn reduces the production of Prostaglandin E2 (PGE2) (PubMed, 2019). PGE2 is a key mediator that acts on the EP3 receptors in the preoptic area of the hypothalamus to elevate the body's thermal set-point during an inflammatory response (NIH, 2021). By lowering central PGE2 levels, antipyretics restore the hypothalamic set-point to normal, triggering heat-loss mechanisms like peripheral vasodilation and sweating (Mayo Clinic, 2023). While effective for symptomatic relief, the use of antipyretics must be balanced against potential side effects such as gastric irritation or liver toxicity depending on the specific agent used.

Other names

Fever reductionPyrolysisAntipyresisFebrile reduction

Inhibition of cyclooxygenase enzymes (COX-1 and COX-2) to reduce the synthesis of Prostaglandin E2 (PGE2) in the preoptic area of the hypothalamus, thereby resetting the thermoregulatory set-point.